Sonja Zweegman, MD, PhD, is head of the Department of Haematology, VU University Medical Center, in Amsterdam, the Netherlands. She is specialized in Multiple Myeloma. Her clinical and translational research is focused on optimisation of the treatment of elderly Multiple Myeloma patients. She is the principal investigator of several (inter)national clinical trials in the elderly. A large myeloma translational research group is incorporated in the Department of Haematology aiming at finding new targets for treatment, with a specific research interest in the role of immune escape mechanisms and microenvironment-induced therapy resistance.
Since 2013, Professor Zweegman has been vice-chairman of the HOVON (the Hemato-Oncology Foundation for Adults in The Netherlands) Multiple Myeloma Working Group. She is a member of the working group on clinical updates of the European School of Hematology (ESH). She is author or co-author of a number of books and many papers published in peer-reviewed journals.